Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate

E-ISSN： 1875-533x|16|16|1978-2000

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.16, 2009-06, pp. : 1978-2000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-07 ,pp. : 107-116

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Mediator Profiling in Pulmonary Disease

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 7, 2011-07 ,pp. : 1026-1052

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

Current Cancer Drug Targets, Vol. 17, Iss. 2, 2017-01 ,pp. : 158-168

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status and Perspectives in Ceramide-Targeting Molecular Medicine

Current Pharmaceutical Design, Vol. 11, Iss. 19, 2005-07 ,pp. : 2479-2487

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3781-3785

Bentham Science Publishers

Access to resources Recommend Favorite